CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially i...Show all
Company (Alive / Active)
Phone: 616-464-5071
161 East Michigan Avenue
4th Floor
Kalamazoo, 49007
Michigan, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Metabolic Solutions Development | $55.9M | Feb 6, 2019 |
| Intarcia Therapeutics | $1712.2M | Mar 12, 2019 |
| CymaBay Therapeutics | $263.6M | Jul 28, 2014 |
| See all 14 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Ppar-sparing compounds for the treatment of metabolic diseases | Jul 21, 2014 | Feb 07, 2017 | Patent |
| Thiazolidinedione analogues | Dec 30, 2014 | Oct 13, 2015 | Patent |
| Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases | Oct 30, 2014 | Sep 08, 2015 | Patent |
| Synthesis for thiazolidinedione compounds | Sep 05, 2014 | Feb 03, 2015 | Patent |
| Novel synthesis for thiazolidinedione compounds | Apr 18, 2011 | Jan 20, 2015 | Patent |
